177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
Clinical trial NCT04663997 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04663997
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-11
- Primary completion
- 2025-08-25
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.